Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$1.19 - $1.94 $11,058 - $18,028
9,293 Added 1.43%
658,548 $862,000
Q1 2023

May 15, 2023

BUY
$1.45 - $3.49 $20,445 - $49,209
14,100 Added 2.22%
649,255 $1.09 Million
Q4 2022

Feb 10, 2023

BUY
$2.5 - $4.44 $514,660 - $914,036
205,864 Added 47.95%
635,155 $1.9 Million
Q3 2022

Nov 14, 2022

BUY
$2.27 - $4.86 $582,808 - $1.25 Million
256,744 Added 148.8%
429,291 $1.88 Million
Q2 2022

Aug 12, 2022

BUY
$3.36 - $4.32 $9,008 - $11,581
2,681 Added 1.58%
172,547 $689,000
Q1 2022

May 13, 2022

BUY
$2.03 - $4.73 $31,444 - $73,267
15,490 Added 10.03%
169,866 $673,000
Q4 2021

Feb 14, 2022

BUY
$4.45 - $9.4 $686,973 - $1.45 Million
154,376 New
154,376 $724,000

About Miromatrix Medical Inc.


  • Ticker MIRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,899,200
  • Description
  • Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified huma...
More about MIRO
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.